logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Hypersecretory Gastropathy

    Medications for Hypersecretory Gastropathy

    FiltersReset Filters
    22 results

    • aciphex

      (rabeprazole sodium)
      Waylis Therapeutics LLC
      Usage: ACIPHEX is indicated for the healing and symptomatic relief of erosive or ulcerative GERD, maintenance of GERD healing, treatment of symptomatic GERD, healing of duodenal ulcers, eradication of Helicobacter pylori to reduce duodenal ulcer recurrence, long-term treatment of pathological hypersecretory conditions, and treatment in adolescents aged 12 and older.

    • esomeprazole magnesium

      (Esomeprazole magnesium)
      Granules Pharmaceuticals Inc.
      Usage: Esomeprazole magnesium delayed-release capsules are indicated for the short-term treatment of erosive esophagitis, GERD symptoms, risk reduction of NSAID-associated gastric ulcers, H. pylori eradication, and long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome in adults and adolescents aged 12-17.

    • famotidine

      (Famotidine)
      Alembic Pharmaceuticals Inc.
      Usage: Famotidine tablets are indicated for treating active duodenal and gastric ulcers, symptomatic nonerosive GERD, and erosive esophagitis due to GERD in patients 40 kg and greater. In adults, they are also used for pathological hypersecretory conditions and to reduce the risk of duodenal ulcer recurrence.

    • famotidine

      (Famotidine)
      Ajanta Pharma USA Inc.
      Usage: Famotidine for oral suspension is indicated for adults to treat active duodenal and gastric ulcers, symptomatic GERD, erosive esophagitis, hypersecretory conditions, and to reduce duodenal ulcer recurrence. In pediatric patients, it treats peptic ulcer disease and GERD, including in infants from birth.

    • famotidine

      (Famotidine)
      Lupin Pharmaceuticals, Inc.
      Usage: Famotidine for oral suspension is indicated for adults to treat active duodenal and gastric ulcers, symptomatic nonerosive GERD, erosive esophagitis due to GERD, pathological hypersecretory conditions, and to reduce duodenal ulcer recurrence. In pediatric patients, it treats peptic ulcer disease and GERD, including infants.

    • lansoprazole

      (Lansoprazole)
      Ajanta Pharma USA Inc.
      Usage: Lansoprazole delayed-release capsules are indicated for the treatment of active duodenal ulcers, NSAID-associated gastric ulcers, GERD, erosive esophagitis, and for the eradication of H. pylori to prevent duodenal ulcer recurrence. It is also used for maintaining healing of ulcers and treating pathological hypersecretory conditions.

    • nexium

      (Esomeprazole magnesium)
      AstraZeneca Pharmaceuticals LP
      Usage: Nexium is indicated for short-term treatment of erosive esophagitis, symptomatic GERD, NSAID-associated gastric ulcers, H. pylori eradication, and long-term management of pathological hypersecretory conditions like Zollinger-Ellison Syndrome in adults and pediatric patients across various age groups.

    • omeprazole

      (OMEPRAZOLE)
      Golden State Medical Supply, Inc.
      Usage: Omeprazole is indicated for the short-term treatment of active duodenal ulcers, benign gastric ulcers, GERD symptoms, and erosive esophagitis, as well as for H. pylori eradication to reduce ulcer recurrence. It is also used long-term for pathological hypersecretory conditions like Zollinger-Ellison syndrome.

    • omeprazole

      (Omeprazole)
      Glenmark Pharmaceuticals Inc., USA
      Usage: Omeprazole delayed-release capsules are used for the short-term treatment of active duodenal and benign gastric ulcers, GERD symptoms, erosive esophagitis, and for the eradication of Helicobacter pylori to prevent ulcer recurrence. It's also indicated for the long-term management of pathological hypersecretory conditions in adults.

    • omeprazole

      (Omeprazole)
      Quallent Pharmaceuticals Health LLC
      Usage: Omeprazole delayed-release capsules are indicated for the short-term treatment of active duodenal ulcers, benign gastric ulcers, gastroesophageal reflux disease (GERD), and erosive esophagitis due to GERD. They're also used for Helicobacter pylori eradication and long-term treatment of pathological hypersecretory conditions in adults.